Ethical issues in international biomedical research : a casebook / edited by James V. Lavery ... [et al.].
Publication details: Oxford ; New York : Oxford University Press, 2007.Description: xxvii, 371 p. ; 24 cmISBN:- 0195179226 (alk. paper)
- 9780195179224 (alk. paper)
- Medicine -- Research -- Moral and ethical aspects -- Case studies
- Medicine -- Research -- Moral and ethical aspects -- Cross-cultural studies
- Human experimentation in medicine -- Moral and ethical aspects -- Case studies
- Human experimentation in medicine -- Moral and ethical aspects -- Cross-cultural studies
- Human Experimentation -- ethics
- Biomedical Research -- ethics
- Internationality
- W 50 E84 2007
Item type | Current library | Call number | Copy number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Book Open Access | Health Sciences Library | W 50 E84 2007 (Browse shelf(Opens below)) | 1 | Available | MBAL22050102 |
Includes bibliographical references and index.
Contents
INTRODUCTION.
PART I: COLLABORATIVE PARTNERSHIP.
Case 1. Community involvement in biodiversity prospecting in Mexico.
Case 2. Selling genes: consulting a genetic population database in Tonga.
Case 3: Substantiality of a fluoride varnish feasability study in Nicaragua.
PART II: SCIENTIFIC VALIDITY.
Case 4: Malarone testing in pregnant women in Thailand.
Case 5: Neglected diseases: Incentives to Conduct Research in Developing Countries: the case of Pharamomycin for visceral leishmaniasis in India.
SECTION III: SCIENTIFIC VALIDITY.
Case 7. The limitations of knowledge: equipsoise and a randomized treatment strategy for malaria in Ethiopia.
Case 8. Controversy surrounding the scientific value of the Vaxgen/Aventis (RV-144) Phase III.
PART IV: FAIR SUBJECT AND COMMUNITY SELECTION.
Case 9. Pharmaceutical research in developing countries: testing a new sufracant in Bolivia.
Case 10: Trading Genes for Toothbrushes: Research with the Aka Pygmy people in the Central African Republic.
Case 11: Test Phase I malaria vaccine: where should the research be conducted?.
PART V: FAVOURABLE RISK/BENEFIT ASSESSMENT.
Case 12: Ethical complcations during an investigation of malaria infection in native Amazonian populations in western Brazil.
Case 13: Access to treatment for trial participants who become infected with HIV during the course of Phase I trials of a preventive HIV vaccine in South Africa.
PART VI: INDEPENDENT REVIEW.
Case 14: How independent is independent review? Partner notification in a study of sexually-transmitted diseases in Mpumalanga, South Africa.
Case 15: Which regulations protect subjects best: preventing HIV status disclosure in a community-based circumcision study in rural Uganda.
PART VII: INFORMED CONSENT.
Case 16: The challenge of informed consent in a genetic epidemiology study of noma in rural Nigeria.
Case 17: Compensation to families who consent to research autopsy for their children in a study of malaria mortality in Malawi: respectful or coercive?.
PART VIII: RESPECT FOR ENROLLED SUBJECTS AND THEIR COMMUNITIES.
Case 18: A randomized trial of low-phytate corn for maternal-infant micronutrient deficiency in Guatemala.
Case 19: Obligations to participants harmed in the course of the N-9 multi-centre vaginal microbicide trial in South Africa.
Case 20: Ethical challenges and controversy in a retrospective study of HIV-1 transmission in Uganda.
Case 21: Protecting subjects in a study of domestic violence in South Africa: what services are researchers obligated to provide?.
There are no comments on this title.